<!DOCTYPE html>
<html class="grunticon">
  <head>
    <script>var _trackAnalytics = function() {};var dataLayer = {/* Specific data layer requirements go here */};var gaDataLayer = [dataLayer];</script>
<meta charset="utf-8" /><script type="text/javascript">(window.NREUM||(NREUM={})).loader_config={licenseKey:"22656e4355",applicationID:"153878993"};window.NREUM||(NREUM={}),__nr_require=function(e,n,t){function r(t){if(!n[t]){var i=n[t]={exports:{}};e[t][0].call(i.exports,function(n){var i=e[t][1][n];return r(i||n)},i,i.exports)}return n[t].exports}if("function"==typeof __nr_require)return __nr_require;for(var i=0;i<t.length;i++)r(t[i]);return r}({1:[function(e,n,t){function r(){}function i(e,n,t){return function(){return o(e,[u.now()].concat(f(arguments)),n?null:this,t),n?void 0:this}}var o=e("handle"),a=e(4),f=e(5),c=e("ee").get("tracer"),u=e("loader"),s=NREUM;"undefined"==typeof window.newrelic&&(newrelic=s);var p=["setPageViewName","setCustomAttribute","setErrorHandler","finished","addToTrace","inlineHit","addRelease"],l="api-",d=l+"ixn-";a(p,function(e,n){s[n]=i(l+n,!0,"api")}),s.addPageAction=i(l+"addPageAction",!0),s.setCurrentRouteName=i(l+"routeName",!0),n.exports=newrelic,s.interaction=function(){return(new r).get()};var m=r.prototype={createTracer:function(e,n){var t={},r=this,i="function"==typeof n;return o(d+"tracer",[u.now(),e,t],r),function(){if(c.emit((i?"":"no-")+"fn-start",[u.now(),r,i],t),i)try{return n.apply(this,arguments)}catch(e){throw c.emit("fn-err",[arguments,this,e],t),e}finally{c.emit("fn-end",[u.now()],t)}}}};a("actionText,setName,setAttribute,save,ignore,onEnd,getContext,end,get".split(","),function(e,n){m[n]=i(d+n)}),newrelic.noticeError=function(e,n){"string"==typeof e&&(e=new Error(e)),o("err",[e,u.now(),!1,n])}},{}],2:[function(e,n,t){function r(e,n){var t=e.getEntries();t.forEach(function(e){"first-paint"===e.name?c("timing",["fp",Math.floor(e.startTime)]):"first-contentful-paint"===e.name&&c("timing",["fcp",Math.floor(e.startTime)])})}function i(e,n){var t=e.getEntries();t.length>0&&c("lcp",[t[t.length-1]])}function o(e){if(e instanceof s&&!l){var n,t=Math.round(e.timeStamp);n=t>1e12?Date.now()-t:u.now()-t,l=!0,c("timing",["fi",t,{type:e.type,fid:n}])}}if(!("init"in NREUM&&"page_view_timing"in NREUM.init&&"enabled"in NREUM.init.page_view_timing&&NREUM.init.page_view_timing.enabled===!1)){var a,f,c=e("handle"),u=e("loader"),s=NREUM.o.EV;if("PerformanceObserver"in window&&"function"==typeof window.PerformanceObserver){a=new PerformanceObserver(r),f=new PerformanceObserver(i);try{a.observe({entryTypes:["paint"]}),f.observe({entryTypes:["largest-contentful-paint"]})}catch(p){}}if("addEventListener"in document){var l=!1,d=["click","keydown","mousedown","pointerdown","touchstart"];d.forEach(function(e){document.addEventListener(e,o,!1)})}}},{}],3:[function(e,n,t){function r(e,n){if(!i)return!1;if(e!==i)return!1;if(!n)return!0;if(!o)return!1;for(var t=o.split("."),r=n.split("."),a=0;a<r.length;a++)if(r[a]!==t[a])return!1;return!0}var i=null,o=null,a=/Version\/(\S+)\s+Safari/;if(navigator.userAgent){var f=navigator.userAgent,c=f.match(a);c&&f.indexOf("Chrome")===-1&&f.indexOf("Chromium")===-1&&(i="Safari",o=c[1])}n.exports={agent:i,version:o,match:r}},{}],4:[function(e,n,t){function r(e,n){var t=[],r="",o=0;for(r in e)i.call(e,r)&&(t[o]=n(r,e[r]),o+=1);return t}var i=Object.prototype.hasOwnProperty;n.exports=r},{}],5:[function(e,n,t){function r(e,n,t){n||(n=0),"undefined"==typeof t&&(t=e?e.length:0);for(var r=-1,i=t-n||0,o=Array(i<0?0:i);++r<i;)o[r]=e[n+r];return o}n.exports=r},{}],6:[function(e,n,t){n.exports={exists:"undefined"!=typeof window.performance&&window.performance.timing&&"undefined"!=typeof window.performance.timing.navigationStart}},{}],ee:[function(e,n,t){function r(){}function i(e){function n(e){return e&&e instanceof r?e:e?c(e,f,o):o()}function t(t,r,i,o){if(!l.aborted||o){e&&e(t,r,i);for(var a=n(i),f=v(t),c=f.length,u=0;u<c;u++)f[u].apply(a,r);var p=s[y[t]];return p&&p.push([b,t,r,a]),a}}function d(e,n){h[e]=v(e).concat(n)}function m(e,n){var t=h[e];if(t)for(var r=0;r<t.length;r++)t[r]===n&&t.splice(r,1)}function v(e){return h[e]||[]}function g(e){return p[e]=p[e]||i(t)}function w(e,n){u(e,function(e,t){n=n||"feature",y[t]=n,n in s||(s[n]=[])})}var h={},y={},b={on:d,addEventListener:d,removeEventListener:m,emit:t,get:g,listeners:v,context:n,buffer:w,abort:a,aborted:!1};return b}function o(){return new r}function a(){(s.api||s.feature)&&(l.aborted=!0,s=l.backlog={})}var f="nr@context",c=e("gos"),u=e(4),s={},p={},l=n.exports=i();l.backlog=s},{}],gos:[function(e,n,t){function r(e,n,t){if(i.call(e,n))return e[n];var r=t();if(Object.defineProperty&&Object.keys)try{return Object.defineProperty(e,n,{value:r,writable:!0,enumerable:!1}),r}catch(o){}return e[n]=r,r}var i=Object.prototype.hasOwnProperty;n.exports=r},{}],handle:[function(e,n,t){function r(e,n,t,r){i.buffer([e],r),i.emit(e,n,t)}var i=e("ee").get("handle");n.exports=r,r.ee=i},{}],id:[function(e,n,t){function r(e){var n=typeof e;return!e||"object"!==n&&"function"!==n?-1:e===window?0:a(e,o,function(){return i++})}var i=1,o="nr@id",a=e("gos");n.exports=r},{}],loader:[function(e,n,t){function r(){if(!x++){var e=E.info=NREUM.info,n=d.getElementsByTagName("script")[0];if(setTimeout(s.abort,3e4),!(e&&e.licenseKey&&e.applicationID&&n))return s.abort();u(y,function(n,t){e[n]||(e[n]=t)}),c("mark",["onload",a()+E.offset],null,"api");var t=d.createElement("script");t.src="https://"+e.agent,n.parentNode.insertBefore(t,n)}}function i(){"complete"===d.readyState&&o()}function o(){c("mark",["domContent",a()+E.offset],null,"api")}function a(){return O.exists&&performance.now?Math.round(performance.now()):(f=Math.max((new Date).getTime(),f))-E.offset}var f=(new Date).getTime(),c=e("handle"),u=e(4),s=e("ee"),p=e(3),l=window,d=l.document,m="addEventListener",v="attachEvent",g=l.XMLHttpRequest,w=g&&g.prototype;NREUM.o={ST:setTimeout,SI:l.setImmediate,CT:clearTimeout,XHR:g,REQ:l.Request,EV:l.Event,PR:l.Promise,MO:l.MutationObserver};var h=""+location,y={beacon:"bam.nr-data.net",errorBeacon:"bam.nr-data.net",agent:"js-agent.newrelic.com/nr-1167.min.js"},b=g&&w&&w[m]&&!/CriOS/.test(navigator.userAgent),E=n.exports={offset:f,now:a,origin:h,features:{},xhrWrappable:b,userAgent:p};e(1),e(2),d[m]?(d[m]("DOMContentLoaded",o,!1),l[m]("load",r,!1)):(d[v]("onreadystatechange",i),l[v]("onload",r)),c("mark",["firstbyte",f],null,"api");var x=0,O=e(6)},{}],"wrap-function":[function(e,n,t){function r(e){return!(e&&e instanceof Function&&e.apply&&!e[a])}var i=e("ee"),o=e(5),a="nr@original",f=Object.prototype.hasOwnProperty,c=!1;n.exports=function(e,n){function t(e,n,t,i){function nrWrapper(){var r,a,f,c;try{a=this,r=o(arguments),f="function"==typeof t?t(r,a):t||{}}catch(u){l([u,"",[r,a,i],f])}s(n+"start",[r,a,i],f);try{return c=e.apply(a,r)}catch(p){throw s(n+"err",[r,a,p],f),p}finally{s(n+"end",[r,a,c],f)}}return r(e)?e:(n||(n=""),nrWrapper[a]=e,p(e,nrWrapper),nrWrapper)}function u(e,n,i,o){i||(i="");var a,f,c,u="-"===i.charAt(0);for(c=0;c<n.length;c++)f=n[c],a=e[f],r(a)||(e[f]=t(a,u?f+i:i,o,f))}function s(t,r,i){if(!c||n){var o=c;c=!0;try{e.emit(t,r,i,n)}catch(a){l([a,t,r,i])}c=o}}function p(e,n){if(Object.defineProperty&&Object.keys)try{var t=Object.keys(e);return t.forEach(function(t){Object.defineProperty(n,t,{get:function(){return e[t]},set:function(n){return e[t]=n,n}})}),n}catch(r){l([r])}for(var i in e)f.call(e,i)&&(n[i]=e[i]);return n}function l(n){try{e.emit("internal-error",n)}catch(t){}}return e||(e=i),t.inPlace=u,t.flag=a,t}},{}]},{},["loader"]);</script>
<meta name="citation_reference" content="" />
<meta name="citation_reference" content="" />
<meta name="citation_reference" content="" />
<meta name="citation_reference" content="citation_title=Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!)
;citation_author=Henao-Restrepo AM;citation_author=Camacho A;citation_author=Longini IM;citation_author=et al;citation_journal_title=Lancet
;citation_volume=389;citation_issue=10068;citation_number=10068;citation_publication_date=2020;citation_firstpage=505;citation_lastpage=518;" />
<meta name="citation_reference" content="" />
<meta name="citation_reference" content="" />
<meta name="citation_reference" content="" />
<meta name="citation_reference" content="" />
<meta name="citation_reference" content="citation_title=The limitations of “vulnerability” as a protection for human research participants
;citation_author=Levine C;citation_author=Faden R;citation_author=Grady C;citation_author=et al;citation_journal_title=Am J Bioeth
;citation_volume=4;citation_issue=3;citation_number=3;citation_publication_date=2020;citation_firstpage=44;citation_lastpage=49;" />
<meta name="citation_reference" content="citation_title=Improving public health requires inclusion of underrepresented populations in research
;citation_author=Spong CY;citation_author=Bianchi DW;citation_journal_title=JAMA
;citation_volume=319;citation_issue=4;citation_number=4;citation_publication_date=2020;citation_firstpage=337;citation_lastpage=338;" />
<meta name="citation_reference" content="" />
<meta name="citation_reference" content="citation_title=Vulnerability of pregnant women in clinical research
;citation_author=van der Zande ISE;citation_author=van der Graaf R;citation_author=Oudijk MA;citation_author=van Delden JJM;citation_journal_title=J Med Ethics
;citation_volume=43;citation_issue=10;citation_number=10;citation_firstpage=657;citation_lastpage=663;" />
<meta name="citation_reference" content="" />
<meta name="citation_reference" content="" />
<meta name="citation_reference" content="" />
<meta name="citation_reference" content="" />
<meta name="citation_reference" content="" />
<meta name="citation_reference" content="" />
<meta name="citation_reference" content="" />
<meta name="citation_reference" content="citation_title=Lessons from the Ebola outbreak: action items for emerging infectious disease preparedness and response
;citation_author=Jacobsen KH;citation_author=Aguirre AA;citation_author=Bailey CL;citation_author=et al;citation_journal_title=Ecohealth
;citation_volume=13;citation_issue=1;citation_number=1;citation_publication_date=2020;citation_firstpage=200;citation_lastpage=212;" />
<meta name="citation_reference" content="" />
<meta name="citation_reference" content="" />
<meta name="citation_reference" content="citation_title=Ethical considerations for vaccination programmes in acute humanitarian emergencies
;citation_author=Moodley K;citation_author=Hardie K;citation_author=Selgelid MJ;citation_author=et al;citation_journal_title=Bull World Health Organ
;citation_volume=91;citation_issue=4;citation_number=4;citation_publication_date=2020;citation_firstpage=290;citation_lastpage=297;" />
<meta name="citation_reference" content="" />
<meta name="citation_reference" content="" />
<meta name="citation_author" content="Archana  Asundi" />
<meta name="citation_author" content="Nahid  Bhadelia" />
<meta name="citation_fulltext_world_readable" content=" " />
<meta name="title" content="Making Emergency Use of Experimental Vaccines Safer | Journal of Ethics | American Medical Association" />
<meta name="citation_title" content="Making Emergency Use of Experimental Vaccines Safer" />
<meta name="twitter:card" content="summary" />
<meta name="citation_abstract" content="Ethical and logistical challenges of deploying experimental vaccines in humanitarian emergencies are exacerbated by a paucity of safety and efficacy data. For outbreaks caused by pathogens with high mortality rates and few treatments" />
<meta name="citation_abstract" content="such as Ebola virus disease" />
<meta name="citation_abstract" content="not offering access to experimental vaccines with some evidence of efficacy can also be ethically suspect. This article recommends (1) gathering more preclinical data about experimental vaccines’ safety and (2) improving research infrastructure to enable participation of a wide range of subjects in affected communities over long trial periods. Motivating these goals would facilitate clearer definitions of population vulnerability and risk acceptability." />
<meta property="og:site_name" content="Journal of Ethics | American Medical Association" />
<meta name="citation_fulltext_html_url" content="https://journalofethics.ama-assn.org/article/making-emergency-use-experimental-vaccines-safer/2020-01" />
<link rel="canonical" href="https://journalofethics.ama-assn.org/article/making-emergency-use-experimental-vaccines-safer/2020-01" />
<meta name="twitter:description" content="How would gathering preclinical data and improving research infrastructure facilitate clearer definitions of “population vulnerability” and “risk acceptability”?" />
<meta name="citation_publisher" content="American Medical Association" />
<meta name="citation_publication_date" content="2020-01-01" />
<meta name="description" content="How would gathering preclinical data and improving research infrastructure facilitate clearer definitions of “population vulnerability” and “risk acceptability”?" />
<meta name="citation_doi" content="10.1001/amajethics.2020.43." />
<meta name="citation_journal_title" content="AMA Journal of Ethics" />
<meta property="og:url" content="https://journalofethics.ama-assn.org/article/making-emergency-use-experimental-vaccines-safer/2020-01" />
<meta name="google-site-verification" content="TBbitFF4VJF1paIv0qHbeEV-7EQ58PPXk8hamar5DkQ" />
<meta property="og:title" content="Making Emergency Use of Experimental Vaccines Safer" />
<meta name="citation_issn" content="2376-6980" />
<meta name="citation_volume" content="22" />
<meta property="og:description" content="How would gathering preclinical data and improving research infrastructure facilitate clearer definitions of “population vulnerability” and “risk acceptability”?" />
<meta name="twitter:image:alt" content="stas1-2001" />
<meta name="twitter:image" content="https://journalofethics.ama-assn.org/sites/journalofethics.ama-assn.org/files/2019-11/stas1-2001.jpg" />
<meta name="citation_issue" content="1" />
<meta name="citation_firstpage" content="43" />
<meta name="citation_lastpage" content="49" />
<meta property="og:image:url" content="https://journalofethics.ama-assn.org/sites/journalofethics.ama-assn.org/files/2019-11/stas1-2001.jpg" />
<meta name="citation_pdf_url" content="https://journalofethics.ama-assn.org/sites/journalofethics.ama-assn.org/files/2019-12/stas1-2001_1.pdf" />
<meta name="Generator" content="Drupal 8 (https://www.drupal.org)" />
<meta name="MobileOptimized" content="width" />
<meta name="HandheldFriendly" content="true" />
<meta name="viewport" content="width=device-width, initial-scale=1.0" />
<link rel="shortcut icon" href="/themes/custom/ama_joe_theme/favicon.ico" type="image/vnd.microsoft.icon" />
<link rel="revision" href="https://journalofethics.ama-assn.org/article/making-emergency-use-experimental-vaccines-safer/2020-01" />

    <title>Making Emergency Use of Experimental Vaccines Safer | Journal of Ethics | American Medical Association</title>
    <link rel="stylesheet" media="all" href="/sites/journalofethics.ama-assn.org/files/css/css_YWh_ejYe3hL0GnWb8DkcgS-U_1pt1EUUqpyeiGj1LRA.css?q6f658" />
<link rel="stylesheet" media="all" href="/sites/journalofethics.ama-assn.org/files/css/css_1SF0285_5RJ3ZNmwHMFlHNM3VZ0ZksMWC2gBJWWZ-Es.css?q6f658" />

    
<!--[if lte IE 8]>
<script src="/sites/journalofethics.ama-assn.org/files/js/js_VtafjXmRvoUgAzqzYTA3Wrjkx9wcWhjP0G4ZnnqRamA.js"></script>
<![endif]-->
<script src="/sites/journalofethics.ama-assn.org/files/js/js_movRD9PPfOBuzV8oawF2KbQk1i7gtQdpJWMvMKX424Q.js"></script>

    <link rel="stylesheet" href="https://use.typekit.net/arm2urd.css">
  </head>
  <body class="">
    <noscript><iframe src="//www.googletagmanager.com/ns.html?id=GTM-MVM33G" height="0" width="0" style="display:none;visibility:hidden"></iframe></noscript><script>(function(w,d,s,l,i){w[l]=w[l]||[];w[l].push({'gtm.start':new Date().getTime(),event:'gtm.js'});var f=d.getElementsByTagName(s)[0],j=d.createElement(s),dl=l!='dataLayer'?'&l='+l:'';j.async=true;j.src='//www.googletagmanager.com/gtm.js?id='+i+dl;f.parentNode.insertBefore(j,f);})(window,document,'script','gaDataLayer','GTM-MVM33G');</script> 
        <a href="#main-content" class="visually-hidden focusable">
      Skip to main content
    </a>
    
      <div class="dialog-off-canvas-main-canvas" data-off-canvas-main-canvas>
    <div class="layout-container">
  <header class ="joe__header" role="banner">
    <div class="container">
      <div class="joe__wordmark">
      <a href="/">
        <h1 class="joe__wordmark__title">AMA Journal of Ethics</h1>
        <h2 class="joe__wordmark__subtitle">Illuminating the Art of Medicine</h2>
      </a>
      </div>
      <button id="search-trigger" class="joe__trigger joe__search-trigger" aria-controls="#joe__site-search">
        <span class="icon-search joe__icon " style="background-image: none;">
           <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100"><title>Search</title><path d="M93.4 86.5L74 67.1c5.4-6.8 8.3-15.3 8.3-24.1C82.3 21.3 64.7 3.7 43 3.7S3.8 21.3 3.8 43c0 21.7 17.6 39.3 39.3 39.3 8.4 0 16.6-2.7 23.4-7.8L86 94.1c1 1 2.3 1.6 3.8 1.6s2.8-.6 3.8-1.6c1.9-2.2 1.9-5.5-.2-7.6zM71.7 43c0 15.8-12.8 28.6-28.6 28.6S14.5 58.8 14.5 43 27.2 14.4 43 14.4 71.7 27.2 71.7 43z"/></svg>
        </span>
      </button>
        
    
      <form action="/article/making-emergency-use-experimental-vaccines-safer/2020-01" method="post" id="site-search-form" accept-charset="UTF-8" class="joe__site-search">
  <div class="js-form-item form-item js-form-type-textfield form-item-site-search js-form-item-site-search form-no-label">
        <input placeholder="Search" id="site-search" data-drupal-selector="edit-site-search" type="text" name="site-search" value="" size="60" maxlength="128" class="form-text required" required="required" aria-required="true" />

        </div>
<input autocomplete="off" data-drupal-selector="form-7fkx4ysjksl6b7nfl0-q3gpyf25mqen347-pls7ffwy" type="hidden" name="form_build_id" value="form-7FkX4ysJksL6b7Nfl0-Q3GPyF25Mqen347_PLs7fFwY" />
<input data-drupal-selector="edit-ama-joe-header-search-bar-form" type="hidden" name="form_id" value="ama_joe_header_search_bar_form" />

<div data-drupal-selector="edit-actions" class="form-actions js-form-wrapper form-wrapper" id="edit-actions">
		 <input data-drupal-selector="edit-submit" type="submit" id="edit-submit" name="op" value="Search" class="button button--primary js-form-submit form-submit" />
	
	 
</div>

</form>


  
            <button id="menu-trigger" class="joe__trigger joe__menu-trigger" aria-controls="#joe__nav-drawer">
  <span class="icon-menu joe__icon " style="background-image: none;">
  <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100"><title>Menu</title><path d="M85.9 26.6H13.1c-3.2 0-5.8-2.6-5.8-5.8S9.9 15 13.1 15H86c3.2 0 5.8 2.6 5.8 5.8s-2.7 5.8-5.9 5.8zM85.9 53.7H13.1c-3.2 0-5.8-2.6-5.8-5.8s2.6-5.8 5.8-5.8H86c3.2 0 5.8 2.6 5.8 5.8s-2.7 5.8-5.9 5.8zM85.9 80.8H13.1c-3.2 0-5.8-2.6-5.8-5.8 0-3.2 2.6-5.8 5.8-5.8H86c3.2 0 5.8 2.6 5.8 5.8-.1 3.2-2.7 5.8-5.9 5.8z"/></svg>
  </span>
</button>
<div id="joe__nav-drawer" class="joe__nav-drawer">
  <nav role="navigation" aria-labelledby="block-ama-joe-theme-main-menu-menu" id="block-ama-joe-theme-main-menu" class="joe__primary-nav">
                      
    <h2 class="visually-hidden" id="block-ama-joe-theme-main-menu-menu">Main navigation</h2>
    

              
              <ul class="joe__primary-nav__list">
              <li class="joe__primary-nav__item">
        <a href="/" data-drupal-link-system-path="&lt;front&gt;">Home</a>
              </li>
          <li class="joe__primary-nav__item">
        <a href="/issues" data-drupal-link-system-path="issues">Issues</a>
              </li>
          <li class="joe__primary-nav__item">
        <a href="/articles" data-drupal-link-system-path="articles">Articles</a>
              </li>
          <li class="joe__primary-nav__item">
        <a href="/cases" data-drupal-link-system-path="cases">Cases</a>
              </li>
          <li class="joe__primary-nav__item">
        <a href="/art-gallery" data-drupal-link-system-path="art-gallery">Art</a>
              </li>
          <li class="joe__primary-nav__item">
        <a href="/podcasts" data-drupal-link-system-path="podcasts">Podcast</a>
              </li>
          <li class="joe__primary-nav__item">
        <a href="/cme" data-drupal-link-system-path="cme">CME</a>
              </li>
        </ul>
  


      </nav>
  <nav class="joe__utility-nav">
    
              <ul class="joe__utility-nav__list">
              <li class="joe__utility-nav__item">
        <a href="/authors" title="Author information" data-drupal-link-system-path="node/11256">For Authors</a>
              </li>
          <li class="joe__utility-nav__item">
        <a href="/call-papers" title="See the upcoming theme issues" data-drupal-link-system-path="node/16911">Call for Papers</a>
              </li>
          <li class="joe__utility-nav__item">
        <a href="/call-artwork" title="call for artwork" data-drupal-link-system-path="node/17046">Call for Artwork</a>
              </li>
          <li class="joe__utility-nav__item">
        <a href="https://journalofethics.ama-assn.org/conley-contests" title="Learn more about the Conley Essay and Art of Medicine Contests">Conley Contests</a>
              </li>
        </ul>
    
              <ul class="joe__utility-nav__list joe__utility-nav__list--right">
              <li class="joe__utility-nav__item">
        <a href="/newsletter-sign" data-drupal-link-system-path="node/11261">Sign Up for Newsletter</a>
                      </li>
          <li class="joe__utility-nav__item">
        <a href="https://twitter.com/journalofethics">Follow Us</a>
                          <span class="icon-twitter joe__icon" style="background-image: none;">
            <svg xmlns="http://www.w3.org/2000/svg" viewBox="0 0 100 100"><title>Twitter</title><path d="M85.2 33.2v2.3c0 23.5-17.9 50.7-50.7 50.7-10.1 0-19.5-2.9-27.3-8 1.4.1 2.8.3 4.3.3 8.3 0 16-2.9 22.1-7.6-7.8-.1-14.4-5.3-16.7-12.4 1.1.3 2.3.3 3.3.3 1.6 0 3.2-.3 4.7-.6-8.2-1.6-14.3-8.8-14.3-17.4v-.3c2.4 1.4 5.2 2.1 8.1 2.3-4.8-3.2-8-8.6-8-14.9 0-3.3.9-6.3 2.4-9 8.8 10.7 22 17.9 36.8 18.6-.3-1.3-.5-2.7-.5-4 0-9.9 8-17.8 17.8-17.8 5.2 0 9.7 2.1 13 5.7 4-.8 7.8-2.3 11.4-4.3-1.3 4.2-4.2 7.7-7.8 9.9 3.5-.4 7.1-1.4 10.2-2.8-2.4 3.3-5.4 6.5-8.8 9z"/></svg>          </span>
              </li>
        </ul>
  


  


  </nav>
</div>

  
    </div>
  </header>

  
  

  

  

  

  <div class="joe__article-hero  " style=background:url(&#039;https://journalofethics.ama-assn.org/sites/journalofethics.ama-assn.org/files/styles/hero_overlay/public/2019-11/stas1-2001.jpg?itok=yptOSSAZ&#039;);background-repeat:no-repeat;background-size:cover;background-position:center;>
    <span class="joe__article-hero__overlay"></span>
  </div>
  <main role="main">
    <div class="container">
    <a id="main-content" tabindex="-1"></a>              
    
      

  
        
        
<article role="article" about="/article/making-emergency-use-experimental-vaccines-safer/2020-01" typeof="schema:Article" class="joe__layout--two-column-left">
  <div id="joe__top" class="joe__page-content joe__article--top" role="article">
    <header class="joe__article-header">
      <a class="joe__flag joe__flag--larger joe__flag--green" href="/issue/culture-context-and-epidemic-containment">
        <div class="joe__flag__type">
          
            State of the Art and Science
      
        </div>
        <div class="joe__flag__date">
          Jan 2020
        </div>
      </a>
            <h2 class="joe__article-header__title"><span property="schema:name">Making Emergency Use of Experimental Vaccines Safer</span>
</h2>
      <div class="joe__article-header__meta">
      

 Archana Asundi, MD and  Nahid Bhadelia, MD      </div>
    </header>
    <div class="joe__article-tools">
      <div class="joe__tool-drawer">
      <div id="citation-drawer" class="joe__tool-drawer__content"><em>AMA J Ethics.</em> 2020;22(1):E43-49. doi: 
            10.1001/amajethics.2020.43.
      </div>
      <button type="button" class=" joe__button--tool tool-drawer__trigger" aria-label="" aria-controls="#citation-drawer">Citation</button>
      </div>
              <a href="/sites/journalofethics.ama-assn.org/files/2019-12/stas1-2001_1.pdf">
          <button type="link" class=" joe__button--tool " aria-label="Download PDF">
            PDF
          </button>
        </a>
            <a target="_blank" href="https://www.altmetric.com/details/doi/10.1001/amajethics.2020.43">
        <button type="link" class=" joe__button--tool " aria-label="Altmetric">Altmetric</button>
      </a>
    </div>
    


<button id="joe__share--trigger" class="joe__share-trigger" title="Open Sharing Options" style=""><span
    class="icon-square-share joe__icon "
    style="background-image: none;"><svg id="Layer_1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 90 90"><style>.st0{fill:#fff}</style><path d="M85.4 0H4.5C2 0 0 2 0 4.5v81C0 88 2 90 4.5 90h81c2.5 0 4.5-2 4.5-4.5v-81C89.9 2 87.9 0 85.4 0z"/><path class="st0" d="M64.5 53.1c-2.7 0-5.2 1.2-6.8 3.1L34.3 46c0-.3.1-.7.1-1s0-.7-.1-1l23.3-10.2c1.6 1.9 4.1 3.1 6.8 3.1 4.9 0 8.9-4 8.9-8.9s-4-8.9-8.9-8.9-8.9 4-8.9 8.9c0 .4 0 .7.1 1L32.3 39.3c-1.6-1.9-4.1-3.1-6.8-3.1-4.9 0-8.9 4-8.9 8.9s4 8.9 8.9 8.9c2.7 0 5.2-1.2 6.8-3.1l23.3 10.2c0 .3-.1.7-.1 1 0 4.9 4 8.9 8.9 8.9s8.9-4 8.9-8.9-3.9-9-8.8-9z"/></svg></span>
</button>

<ul class="joe__share">
  <li class="joe__share__item">
    <a
      href="https://twitter.com/intent/tweet?text=Making Emergency Use of Experimental Vaccines Safer&via=journalofethics&url=https://journalofethics.ama-assn.org/article/making-emergency-use-experimental-vaccines-safer/2020-01"><span
        class="icon-square-twitter joe__icon"
        style="background-image: none;"><svg id="Layer_1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 90 90"><style>.st0{fill:#fff}</style><path d="M85.4 0H4.5C2 0 0 2 0 4.5v81C0 88 2 90 4.5 90h81c2.5 0 4.5-2 4.5-4.5v-81C89.9 2 87.9 0 85.4 0z"/><path class="st0" d="M71.7 22.6c-2.3 1.3-4.8 2.3-7.4 2.8-2.2-2.3-5.2-3.7-8.5-3.7-6.4 0-11.6 5.2-11.6 11.6 0 .9.1 1.8.3 2.6-9.7-.5-18.2-5.1-23.9-12.1-1 1.7-1.6 3.7-1.6 5.8 0 4 2.1 7.5 5.2 9.6-1.9 0-3.7-.5-5.3-1.4v.1c0 5.5 4 10.3 9.3 11.3-.9.3-2 .4-3 .4-.8 0-1.5-.1-2.2-.2 1.5 4.6 5.7 7.9 10.8 8-4 3.1-9 5-14.4 5-.9 0-1.8-.1-2.7-.2 5.1 3.3 11.2 5.2 17.7 5.2 21.3 0 32.9-17.6 32.9-32.9V33c2.2-1.7 4.2-3.7 5.9-5.8-2 .9-4.3 1.5-6.6 1.8 2.4-1.4 4.3-3.7 5.1-6.4z"/></svg></span></a>
  </li>
  <li class="joe__share__item">
    <a href="https://www.facebook.com/sharer.php?u=https://journalofethics.ama-assn.org/article/making-emergency-use-experimental-vaccines-safer/2020-01"><span class="icon-square-facebook joe__icon"
                                                                                 style="background-image: none;"><svg id="Layer_1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 90 90"><style>.st0{fill:#fff}</style><path d="M85.2 90.1c2.7 0 5-2.2 5-5v-80C90 2.2 87.8 0 85 0H5C2.3 0 0 2.2 0 5v80c0 2.7 2.2 5 5 5l80.2.1z"/><path class="st0" d="M63.6 90.1V55.3h11.7L77 41.7H63.5V33c0-3.9 1-6.6 6.7-6.6h7.2V14.2c-1.3-.1-5.5-.5-10.5-.5-10.4 0-17.5 6.3-17.5 17.9v10H37.7v13.6h11.7V90"/></svg>
  </span></a>
  </li>
  <li class="joe__share__item">
    <a href="https://www.linkedin.com/shareArticle?url=https://journalofethics.ama-assn.org/article/making-emergency-use-experimental-vaccines-safer/2020-01"><span
        class="icon-square-linkedin joe__icon"
        style="background-image: none;"><svg id="Layer_1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 90 90"><style>.st0{fill:#fff}</style><path d="M83.3 0H6.6C2.9 0 0 2.9 0 6.5v77C0 87.1 3 90 6.6 90h76.7c3.7 0 6.7-2.9 6.7-6.5v-77C90 2.9 87 0 83.3 0z"/><path class="st0" d="M57.4 35.8c-5 0-8.3 2.7-9.6 5.3h-.2v-4.4h-9.8v32.9H48V53.3c0-4.3.8-8.4 6.1-8.4 5.2 0 5.3 4.9 5.3 8.7v16H69.7V51.5c0-8.9-1.9-15.7-12.3-15.7zM21.1 36.7h10.2v32.9H21.1zM26.2 20.4c-3.2 0-5.9 2.6-5.9 5.9 0 3.2 2.6 5.9 5.9 5.9 3.3 0 6-2.7 5.9-5.9 0-3.2-2.6-5.9-5.9-5.9z"/></svg></span></a>
  </li>
  <li class="joe__share__item">
    <a href="/cdn-cgi/l/email-protection#7b44080e19111e180f46361a1012151c5b3e161e091c1e1518025b2e081e5b141d5b3e030b1e0912161e150f1a175b2d1a181812151e085b281a1d1e095d19141f0246130f0f0b0841545411140e09151a17141d1e0f13121808551a161a561a0808155514091c541a090f1218171e54161a1012151c561e161e091c1e151802560e081e561e030b1e0912161e150f1a17560d1a181812151e0856081a1d1e0954494b494b564b4a"><span class="icon-square-email joe__icon"
                                                                                 style="background-image: none;"><svg id="Layer_1" xmlns="http://www.w3.org/2000/svg" viewBox="0 0 90 90"><style>.st0{fill:#fff}</style><path d="M85.4 0H4.5C2 0 0 2 0 4.5v81C0 88 2 90 4.5 90h81c2.5 0 4.5-2 4.5-4.5v-81C89.9 2 87.9 0 85.4 0z"/><title>email</title><path class="st0" d="M45.3 54.3c-1.2 0-2.3-.4-3.1-1.1L18.6 32.8v35h52.8V33.4l-23 19.8c-.8.7-1.9 1.1-3.1 1.1z"/><path class="st0" d="M71.3 22.2H18.8l26.6 22.9 26-22.5h-.1z"/></svg></span></a>
  </li>
</ul>
  </div>
    <div class="joe__page-content joe__article">
                <h2>Abstract</h2>
          
            <p>Ethical and logistical challenges of deploying experimental vaccines in humanitarian emergencies are exacerbated by a paucity of safety and efficacy data. For outbreaks caused by pathogens with high mortality rates and few treatments, such as Ebola virus disease, not offering access to experimental vaccines with some evidence of efficacy can also be ethically suspect. This article recommends (1) gathering more preclinical data about experimental vaccines’ safety and (2) improving research infrastructure to enable participation of a wide range of subjects in affected communities over long trial periods. Motivating these goals would facilitate clearer definitions of <em>population</em> <em>vulnerability</em> and <em>risk acceptability</em>.</p>
      
            
            <h3><strong>Risk of Disease vs Risk of Experimental Vaccination</strong></h3>
<p>Safe and effective vaccination programs are critical to mitigating disease outbreaks, but vaccine deployment can be fraught with logistical challenges and ethical questions that vary with the environments in which programs are implemented. Effectively deploying experimental vaccines for emerging infectious diseases relies on policy and research infrastructure to ensure safe, ethical research during emergencies. The complexity of these challenges was apparent during the management of recent Ebola virus disease (EVD) epidemics. At the time of the 2013-2016 West African outbreak, effective management was hampered by, among other things, a lack of licensed vaccines and treatments to deploy to control EVD.<sup>1,2</sup> In the midst of global community members’ push to initiate clinical trials for experimental vaccines and therapeutics, discussions arose about which criteria should be used to distribute experimental vaccines among vulnerable groups, particularly those in resource-limited settings.<sup>3</sup> The current North Kivu EVD outbreak in the Democratic Republic of the Congo (DRC) suggests a continuing need to consider distribution criteria and to develop strategies for anticipating and addressing ethical and logistical questions.</p>
<p>During recent EVD outbreaks, whether experimental recombinant vesicular stomatitis virus-based vaccine (rVSV-ZEBOV) should be used in pregnant and lactating women and in children under one year of age has raised ethical questions. During the 2013-2016 West African Ebola epidemic, members of these populations were excluded from Ebola ça Suffit! trials.<sup>4</sup> Although the World Health Organization (WHO) Research Ethics Review Committee guided implementation of trials during that outbreak and requested amendments to the protocol to include members of these populations as subjects, it later relented, as further review was seen as delaying trial initiation and “potential benefit for all.”<sup>5</sup> In 2019, the DRC National Ethics Committee approved inclusion of pregnant or lactating women and children in a large experimental rVSV vaccination campaign that was underway but required close follow-up and limited distribution to areas where Ebola was being actively transmitted.<sup>6</sup> This committee’s decision highlights that comparing vulnerable community members’ risk of harm from EVD to their risk of harm from rVSV tends to be considered in decisions about whether, where, and with whom to use experimental vaccines.</p>
<p>A first question to ask about experimental vaccine administration among vulnerable populations in emergent situations is this: How should the <a href="https://journalofethics.ama-assn.org/article/vulnerable-populations-medicine-race-and-presumptions-identity/2011-07">concept of <em>vulnerability</em></a> be defined? Individual, social, cultural, and scientific variables should be prioritized in a definition of this concept and considered with reference to a specific situation or circumstance. We argue that members of vulnerable populations can more safely participate in experimental vaccine trials that (1) gather preclinical data and (2) bolster research infrastructure that enables diverse enrollment and long-term follow-up.</p>
<h3><strong>Defining Vulnerability</strong></h3>
<p>In research ethics, a vulnerable population is generally thought to be one whose members’ ability to consent to participate in a research protocol is compromised (eg, through lack of competency, illiteracy, poverty, or inability to communicate). A Canadian Tri-Council Policy Statement (TCPS2) more generally defines vulnerability as “diminished ability to fully safeguard one’s own interests in the context of a specific research project” due to “limited decision-making capacity or limited access to social goods, such as rights, opportunity, and power.”<sup>7</sup> Vulnerability “may require greater effort to minimize risks to participants and/or maximize potential benefits” in order that they be treated justly.<sup>8</sup></p>
<blockquote class="joe__inline-quote joe__inline-quote--left"><p paraeid="{825f2247-8070-4b05-bcea-0c4b171b272c}{137}" paraid="8962669">More often than not, members of populations considered vulnerable are excluded from clinical trials. </p>
</blockquote>
<p>Applying this definition of vulnerability responsibly requires considering that observers can differ in their perceptions of a subject’s moral agency.<sup>9</sup> For example, during an outbreak, individuals or communities might not perceive themselves as vulnerable, although regulatory bodies or health care organizations do, and vice versa. Moreover, simply identifying characteristics that confer “vulnerability” can also be challenging largely because they can consist of both individual traits—including young age, ethnicity, race, gender, or general or mental health status—and particular contexts that apply to an entire community.</p>
<p>How we define vulnerability shapes how those seen as vulnerable are treated and influences opportunities they are offered. As examples, the Ebola ça Suffit! trial prioritized vaccination for subjects exposed to the virus who were not pregnant, breastfeeding, or severely ill; other trials have included health care workers as subjects, excluding pregnant or lactating women.<sup>4</sup> More often that not, members of populations considered vulnerable are excluded from clinical trials.<sup>10</sup> Although pregnant women tend to suffer high mortality from EVD,<sup>11</sup> they and members of other groups have been excluded from clinical EVD trials.<sup>11</sup> Recently, there has been a <a href="https://journalofethics.ama-assn.org/article/why-marginalization-not-vulnerability-can-best-identify-people-need-special-medical-and-nutrition/2018-10">shift toward not labeling</a> populations as vulnerable,<sup>11,12</sup> but removing protections justly and equitably requires input and buy-in from members of these populations, which is difficult to accomplish during an outbreak.</p>
<p>EVD outbreaks have occurred—and continue to occur—in settings fraught with armed conflict and displacement,<sup>14</sup> which exacerbate individuals’ and communities’ vulnerability. Postconflict food insecurity and lack of health care infrastructure in West Africa likely heightened susceptibility to EVD during the 2014 epidemic and helped propagate it.<sup>15,16</sup> These conditions persist in the ongoing epidemic in the DRC, where conflict has made tracing contacts difficult, complexified vaccine investigation, and led some to switch to mass vaccination strategies. Such factors must contextualize how we define and understand concepts such as <em>vulnerability</em> and even <em>emergency</em>, which the WHO defines as the co-existence of outbreak along with either a man-made or natural condition that could cause disruption to health care services.<sup>17</sup> Since context can be dynamic, the process of defining key concepts should also be dynamic. Therefore, international and local agencies should develop close relationships with communities to keep abreast of geopolitical shifts that might influence assessments of vulnerability.</p>
<p>The state of medical science related to emerging diseases like EVD also matters to how vulnerability is defined. A change in clinical standards of care for a particular disease that alters the risk-benefit profile used in individuals’ and agencies’ decision making should also be regarded as a key variable in understanding and defining vulnerability. For example, populations’ susceptibility to EVD during the 2013-2016 epidemic largely hinged on lack of alternatives to <a href="https://journalofethics.ama-assn.org/article/expanded-access-investigational-drugs-what-physicians-and-public-need-know-about-fda-and-corporate/2015-12">experimental drugs</a> to prevent and treat EVD, which likely affected subjects’ decision making about whether to participate in trials. New therapeutic and investigational vaccines have emerged since then,<sup>18</sup> which have altered risk-benefit profiles of communities undergoing an epidemic and will likewise critically shape conceptions of vulnerability. The changing medical context suggests the importance of determinations of vulnerability being made and reassessed continuously by regulatory committees or global health organizations with regular input from affected communities.</p>
<h3><strong>Inclusion and Safety</strong></h3>
<p>Several reports, including a recent review by the Pregnancy Research Ethics for Vaccines, Epidemics, and New Technologies (PREVENT) Working Group, highlight how exclusion of vulnerable groups, including pregnant women and children, from research can result in their not having access to experimental vaccines during emergencies.<sup>19</sup> This report’s key recommendations for including pregnant women in vaccine research set good milestones to follow for research with other vulnerable populations, however defined in a particular situation.</p>
<ol>
<li><em>Gather preclinical data on safety of experimental vaccine use in vulnerable populations.</em> The PREVENT group recommends using advanced technology to study immune responses of pregnant women and children and recommends creation of market incentives to include vulnerable subgroups in research.<sup>19</sup> These efforts should also seek to augment knowledge about use of experimental vaccines in persons with HIV and highly prevalent co-infections that might lead to biological vulnerability to disease.<sup>6</sup></li>
<p>
<li><em>Enable safe enrollment of vulnerable subjects in vaccine trials during crises</em>. Reports have stressed the importance of building surveillance and health information systems to allow improved capture of the outcomes of experimental vaccine deployment, particularly in vulnerable populations.<sup>19,20</sup> Aside from strengthening national health systems, building research capacity in countries where Ebola and other pathogens on the WHO’s priority diseases list pose risk can motivate safe deployment of experimental vaccines during outbreaks.<sup>21</sup> A review of clinical trials conducted during the 2013-2016 EVD epidemic by a committee of the National Academies of Sciences, Engineering, and Medicine suggests the importance of long-standing research engagement to enable timely deployment of investigational agents in communities at risk.<sup>22</sup></li>
<p>
<li><em>Cultivate long-term, trusting relationships. </em>The WHO has developed a framework for ethical decision making concerning use of experimental vaccines during emergencies.<sup>17,23</sup> In addition, perceptions of risks and benefits of groups considered to be vulnerable should inform community participation strategies. One recent study found that many subjects in an Ebola vaccine trial were motivated by altruism, curiosity, hope, health seeking, and notions of exchange.<sup>24</sup> Understanding the role of these values in subjects’ decisions about whether to enroll in a protocol suggest that engagement with local leaders and decision makers is key when discussing experimental vaccine deployment in an emergency and is critical for motivating trust. Due to mistrust, 2 Ebola vaccine trials were suspended in Ghana.<sup>25</sup></li>
</ol>
<h3><strong>Conclusions</strong></h3>
<p>Ethical questions about deploying experimental vaccines during recent and ongoing EVD outbreaks are complex and multifaceted and require attention to dynamic context. Navigating collaborative responses to these questions is aided by contextualizing definitions of <em>vulnerability </em>and <em>emergency</em>; preparedness; nourishing ongoing and sustainable partnerships with people in local communities where outbreaks tend to recur, including through developing trusting communication; and investing in research infrastructure.</p>

      
      <div class="joe__page-content--article" role="article">
                  <div class="joe__tags">
            <h2 class="joe__tags-title">Read More</h2>
                  <ul class="joe__tags-list">
              <li class="joe__tag"><a href="/taxonomy/public-healthclinical-research" hreflang="en">Public health/Clinical research</a>,</li>
              <li class="joe__tag"><a href="/taxonomy/clinical-researchvulnerable-populations" hreflang="en">Clinical research/Vulnerable populations</a>,</li>
              <li class="joe__tag"><a href="/taxonomy/global-healthglobal-health-system-development" hreflang="en">Global health/Global health system development</a>,</li>
              <li class="joe__tag"><a href="/taxonomy/justiceequitable-care" hreflang="en">Justice/Equitable care</a>,</li>
              <li class="joe__tag"><a href="/taxonomy/public-healthdisaster-preparedness" hreflang="en">Public health/Disaster preparedness</a>,</li>
              <li class="joe__tag"><a href="/taxonomy/infectious-diseasesepidemics" hreflang="en">Infectious diseases/Epidemics</a></li>
          </ul>
  
          </div>
                          <div class="joe__references">
            <h3 class="joe__title-label">References</h3>
            <ol class="joe__references__list">
              
                
<li> 
  <p>Kaner J, Schaack S. Understanding Ebola: the 2014 epidemic. <em>Global Health</em>. 2016;12(1):53.</p>
<div class="joe__references__item-links">
	
         <a href="https://doi.org/10.1186/s12992-016-0194-4">View Article</a>
       <a href="https://www.ncbi.nlm.nih.gov/pubmed?term=12%5Bvolume%5D%20AND%201%5Bissue%5D%20AND%2053%5Bpage%5D%20AND%202016%5Bpdat%5D%20AND%20Understanding%20Ebola%3A%20the%202014%20epidemic&amp;TransSchema=title&amp;cmd=detailssearch">PubMed</a>
       <a href="https://scholar.google.com/scholar_lookup?title=Understanding%20Ebola%3A%20the%202014%20epidemic&amp;author=Kaner%20J%2C%20Schaack%20S.&amp;publication_year=2016">Google Scholar</a>
       
</div>
</li>

              
<li> 
  <p>Cenciarelli O, Pietropaoli S, Malizia A, et al. Ebola virus disease 2013-2014 outbreak in West Africa: an analysis of the epidemic spread and response. <i>Int J Microbiol</i>. 2015;2015:769121.</p>

<div class="joe__references__item-links">
	
         <a href="https://dx.doi.org/10.1155/2015/769121">View Article</a>
       <a href="https://www.ncbi.nlm.nih.gov/pubmed?term=Ebola%20virus%20disease%202013-2014%20outbreak%20in%20West%20Africa%3A%20an%20analysis%20of%20the%20epidemic%20spread%20and%20response&amp;TransSchema=title&amp;cmd=detailssearch">PubMed</a>
       <a href="https://scholar.google.com/scholar_lookup?title=Ebola%20virus%20disease%202013-2014%20outbreak%20in%20West%20Africa%3A%20an%20analysis%20of%20the%20epidemic%20spread%20and%20response&amp;author=Cenciarelli%20O%2C%20Pietropaoli%20S%2C%20Malizia%20A%2C%20et%20al.&amp;publication_year=2013">Google Scholar</a>
       
</div>
</li>

              
<li> 
  <p>World Health Organization. (WHO) Ethical considerations for use of unregistered interventions for Ebola viral disease: report of an advisory panel to WHO. <a href="https://apps.who.int/iris/bitstream/handle/10665/130997/WHO_HIS_KER_GHE_14.1_eng.pdf;jsessionid=6AD0D5B55A7075578987E69693C22B7C?sequence=1" target="_blank">https://apps.who.int/iris/bitstream/handle/10665/130997/WHO_HIS_KER_GHE_14.1_eng.pdf;jsessionid=6AD0D5B55A7075578987E69693C22B7C?sequence=1</a>. Published 2014. Accessed November 11, 2019.</p>

</li>

              
<li>
         Henao-Restrepo AM,       Camacho A,       Longini IM,       et al.       
               <span>Efficacy and effectiveness of an rVSV-vectored vaccine in preventing Ebola virus disease: final results from the Guinea ring vaccination, open-label, cluster-randomised trial (Ebola Ca Suffit!).</span>
       
               <span><i>Lancet</i>.</span>
        
 2017;389(10068):505-518. 
<div class="joe__references__item-links">
	
         <a href="https://doi.org/10.1016/S0140-6736(16)32621-6">View Article</a>
       <a href="https://www.ncbi.nlm.nih.gov/pubmed?term=389%5Bvolume%5D%20AND%2010068%5Bissue%5D%20AND%20505%5Bpage%5D%20AND%202017%5Bpdat%5D%20AND%20Efficacy%20and%20effectiveness%20of%20an%20rVSV-vectored%20vaccine%20in%20preventing%20Ebola%20virus%20disease%3A%20final%20results%20from%20the%20Guinea%20ring%20vaccination%2C%20open-label%2C%20cluster-randomised%20trial%20%28Ebola%20Ca%20Suffit%21%29&amp;TransSchema=title&amp;cmd=detailssearch">PubMed</a>
       <a href="https://scholar.google.com/scholar_lookup?title=Efficacy%20and%20effectiveness%20of%20an%20rVSV-vectored%20vaccine%20in%20preventing%20Ebola%20virus%20disease%3A%20final%20results%20from%20the%20Guinea%20ring%20vaccination%2C%20open-label%2C%20cluster-randomised%20trial%20%28Ebola%20Ca%20Suffit%21%29&amp;author=Henao-Restrepo%20AM%2C%20Camacho%20A%2C%20Longini%20IM%2C%20et%20al.&amp;publication_year=2017">Google Scholar</a>
       
</div>
</li>

              
<li> 
  <p>Alirol E, Kuesel AC, Guraiib MM, de la Fuente-Nunez V, Saxena A, Gomes MF. Ethics review of studies during public health emergencies—the experience of the WHO ethics review committee during the Ebola virus disease epidemic. <i>BMC Med Ethics</i>. 2017;18(1):43.</p>

<div class="joe__references__item-links">
	
         <a href="https://doi.org/10.1186/s12910-017-0201-1">View Article</a>
       <a href="https://scholar.google.com/scholar_lookup?title=Ethics%20review%20of%20studies%20during%20public%20health%20emergencies%E2%80%94the%20experience%20of%20the%20WHO%20ethics%20review%20committee%20during%20the%20Ebola%20virus%20disease%20epidemic&amp;author=Alirol%20E%2C%20Kuesel%20AC%2C%20Guraiib%20MM%2C%20de%20la%20Fuente-Nunez%20V%2C%20Saxena%20A%2C%20Gomes%20MF.&amp;publication_year=2017">Google Scholar</a>
       
</div>
</li>

              
<li> 
  <p>Strategic Advisory Group of Experts (SAGE) on Immunization. SAGE interim recommendations on vaccination against Ebola virus disease (EVD). <a href="https://www.who.int/immunization/interim_ebola_recommendations_feb_2019.pdf" target="_blank">https://www.who.int/immunization/interim_ebola_recommendations_feb_2019.pdf</a>. Published February 20, 2019. Accessed November 11, 2019.</p>

</li>

              
<li> 
  <p>da Silva RE, Amato AA, Guilhem DB, de Carvalho MR, Lima EDC, Novaes M. Factors contributing to exacerbating vulnerabilities in global clinical trials. <i>Front Pharmacol</i>. 2017;8:999.</p>

<div class="joe__references__item-links">
	
         <a href="https://doi.org/10.3389/fphar.2017.00999">View Article</a>
       <a href="https://www.ncbi.nlm.nih.gov/pubmed?term=2017%5Bpdat%5D%20AND%20Factors%20cContributing%20to%20eExacerbating%20vVulnerabilities%20in%20gGlobal%20cClinical%20tTrials&amp;TransSchema=title&amp;cmd=detailssearch">PubMed</a>
       <a href="https://scholar.google.com/scholar?hl=en&amp;as_sdt=0%2C5&amp;q=Factors%20Contributing%20to%20Exacerbating%20Vulnerabilities%20in%20Global%20Clinical%20Trials&amp;btnG=">Google Scholar</a>
       
</div>
</li>

              
<li> 
  <p>Canadian Institutes of Health Research; Natural Sciences and Engineering Research Council of Canada; Social Sciences and Humanities Research Council of Canada. <i>Tri-Council Policy Statement: Ethical Conduct for Research Involving Humans</i>. <a href="http://www.frqnt.gouv.qc.ca/documents/10191/186009/TCPS2.+pdf/6a8ab915-431b-428d-aa86-b22ca5c78053" target="_blank">http://www.frqnt.gouv.qc.ca/documents/10191/186009/TCPS2.+pdf/6a8ab915-431b-428d-aa86-b22ca5c78053</a>. Published 2014. Accessed October 8, 2019.</p>

</li>

              
<li>
         Levine C,       Faden R,       Grady C,       et al.       
               <span>The limitations of “vulnerability” as a protection for human research participants.</span>
       
               <span><i>Am J Bioeth</i>.</span>
        
 2004;4(3):44-49. 
<div class="joe__references__item-links">
	
         <a href="https://doi.org/10.1080/15265160490497083">View Article</a>
       <a href="https://www.ncbi.nlm.nih.gov/pubmed?term=4%5Bvolume%5D%20AND%203%5Bissue%5D%20AND%2044%5Bpage%5D%20AND%202004%5Bpdat%5D%20AND%20The%20limitations%20of%20%E2%80%9Cvulnerability%E2%80%9D%20as%20a%20protection%20for%20human%20research%20participants&amp;TransSchema=title&amp;cmd=detailssearch">PubMed</a>
       <a href="https://scholar.google.com/scholar_lookup?title=The%20limitations%20of%20%E2%80%9Cvulnerability%E2%80%9D%20as%20a%20protection%20for%20human%20research%20participants&amp;author=Levine%20C%2C%20Faden%20R%2C%20Grady%20C%2C%20et%20al.&amp;publication_year=2004">Google Scholar</a>
       
</div>
</li>

              
<li>
         Spong CY,       Bianchi DW.       
               <span>Improving public health requires inclusion of underrepresented populations in research.</span>
       
               <span><i>JAMA</i>.</span>
        
 2018;319(4):337-338. 
<div class="joe__references__item-links">
	
         <a href="https://doi.org/10.1001/jama.2017.19138">View Article</a>
       <a href="https://www.ncbi.nlm.nih.gov/pubmed?term=319%5Bvolume%5D%20AND%204%5Bissue%5D%20AND%20337%5Bpage%5D%20AND%202018%5Bpdat%5D%20AND%20Improving%20public%20health%20requires%20inclusion%20of%20underrepresented%20populations%20in%20research&amp;TransSchema=title&amp;cmd=detailssearch">PubMed</a>
       <a href="https://scholar.google.com/scholar_lookup?title=Improving%20public%20health%20requires%20inclusion%20of%20underrepresented%20populations%20in%20research&amp;author=Spong%20CY%2C%20Bianchi%20DW.&amp;publication_year=2018">Google Scholar</a>
       
</div>
</li>

              
<li> 
  <p>Gomes MF, de la Fuente-Núñez V, Saxena A, Kuesel AC. Protected to death: systematic exclusion of pregnant women from Ebola virus disease trials. <i>Reprod Health</i>. 2017;14(suppl 3):172.</p>

<div class="joe__references__item-links">
	
         <a href="https://doi.org/10.1186/s12978-017-0430-2">View Article</a>
       <a href="https://www.ncbi.nlm.nih.gov/pubmed?term=2017%5Bpdat%5D%20AND%20Protected%20to%20death%3A%20systematic%20exclusion%20of%20pregnant%20women%20from%20Ebola%20virus%20disease%20trials&amp;TransSchema=title&amp;cmd=detailssearch">PubMed</a>
       <a href="https://scholar.google.com/scholar_lookup?title=Protected%20to%20death%3A%20systematic%20exclusion%20of%20pregnant%20women%20from%20Ebola%20virus%20disease%20trials&amp;author=Gomes%20MF%2C%20de%20la%20Fuente-N%FA%F1&amp;publication_year=2017">Google Scholar</a>
       
</div>
</li>

              
<li>
         van der Zande ISE,       van der Graaf R,       Oudijk MA,       van Delden JJM.       
               <span>Vulnerability of pregnant women in clinical research.</span>
       
               <span><i>J Med Ethics</i>.</span>
        
 43(10):657-663. 
<div class="joe__references__item-links">
	
         <a href="https://doi.org/10.1136/medethics-2016-103955">View Article</a>
       <a href="https://www.ncbi.nlm.nih.gov/pubmed?term=43%5Bvolume%5D%20AND%2010%5Bissue%5D%20AND%20657%5Bpage%5D%20AND%202017%5Bpdat%5D%20AND%20Vulnerability%20of%20pregnant%20women%20in%20clinical%20research&amp;TransSchema=title&amp;cmd=detailssearch">PubMed</a>
       <a href="https://scholar.google.com/scholar_lookup?title=Vulnerability%20of%20pregnant%20women%20in%20clinical%20research&amp;author=van%20der%20Zande%20ISE%2C%20van%20der%20Graaf%20R%2C%20Oudijk%20MA%2C%20van%20Delden%20JJM.&amp;publication_year=2017">Google Scholar</a>
       
</div>
</li>

              
<li> 
  <p>Task Force on Research Specific to Pregnant Women and Lactating women, US Department of Health and Human Services. <i>Report to Secretary, Health and Human Services, Congress</i>. <a href="https://www.nichd.nih.gov/sites/default/files/2018-09/PRGLAC_Report.pdf" target="_blank">https://www.nichd.nih.gov/sites/default/files/2018-09/PRGLAC_Report.pdf</a>. Published September 2018. Accessed November 11, 2019.</p>

</li>

              
<li> 
  <p>McPake B, Witter S, Ssali S, Wurie H, Namakula J, Ssengooba F. Ebola in the context of conflict affected states and health systems: case studies of Northern Uganda and Sierra Leone. <i>Confl Health</i>. 2015;9:23.</p>

<div class="joe__references__item-links">
	
         <a href="https://doi.org/10.1186/s13031-015-0052-7">View Article</a>
       <a href="https://www.ncbi.nlm.nih.gov/pubmed?term=2015%5Bpdat%5D%20AND%20Ebola%20in%20the%20context%20of%20conflict%20affected%20states%20and%20health%20systems%3A%20case%20studies%20of%20Northern%20Uganda%20and%20Sierra%20Leone&amp;TransSchema=title&amp;cmd=detailssearch">PubMed</a>
       <a href="https://scholar.google.com/scholar_lookup?title=Ebola%20in%20the%20context%20of%20conflict%20affected%20states%20and%20health%20systems%3A%20case%20studies%20of%20Northern%20Uganda%20and%20Sierra%20Leone&amp;author=McPake%20B%2C%20Witter%20S%2C%20Ssali%20S%2C%20Wurie%20H%2C%20Namakula%20J%2C%20Ssengooba%20F.&amp;publication_year=2015">Google Scholar</a>
       
</div>
</li>

              
<li> 
  <p>Stanturf JA, Goodrick SL, Warren ML Jr, Charnley S, Stegall CM. Social vulnerability and Ebola virus disease in rural Liberia. <i>PloS One</i>. 2015;10(9):e0137208.</p>

<div class="joe__references__item-links">
	
         <a href="https://doi.org/10.1371/journal.pone.0137208">View Article</a>
       <a href="https://www.ncbi.nlm.nih.gov/pubmed?term=2015%5Bpdat%5D%20AND%20Social%20vulnerability%20and%20Ebola%20virus%20disease%20in%20rural%20Liberia&amp;TransSchema=title&amp;cmd=detailssearch">PubMed</a>
       <a href="https://scholar.google.com/scholar_lookup?title=Social%20vulnerability%20and%20Ebola%20virus%20disease%20in%20rural%20Liberia&amp;author=Stanturf%20JA%2C%20Goodrick%20SL%2C%20Warren%20ML%20Jr%2C%20Charnley%20S%2C%20Stegall%20CM.&amp;publication_year=2015">Google Scholar</a>
       
</div>
</li>

              
<li> 
  <p>Coltart CE, Lindsey B, Ghinai I, Johnson AM, Heymann DL. The Ebola outbreak, 2013-2016: old lessons for new epidemics. <i>Philos Trans R Soc Lond B Biol Sci</i>. 2017;372(1721):20160297.</p>

<div class="joe__references__item-links">
	
         <a href="https://doi.org/10.1098/rstb.2016.0297">View Article</a>
       <a href="https://www.ncbi.nlm.nih.gov/pubmed?term=372%5Bvolume%5D%20AND%201721%5Bissue%5D%20AND%2020160297%5Bpage%5D%20AND%202017%5Bpdat%5D%20AND%20The%20Ebola%20outbreak%2C%202013-2016%3A%20old%20lessons%20for%20new%20epidemics&amp;TransSchema=title&amp;cmd=detailssearch">PubMed</a>
       <a href="https://scholar.google.com/scholar_lookup?title=The%20Ebola%20outbreak%2C%202013-2016%3A%20old%20lessons%20for%20new%20epidemics&amp;author=Coltart%20CE%2C%20Lindsey%20B%2C%20Ghinai%20I%2C%20Johnson%20AM%2C%20Heymann%20DL.&amp;publication_year=2017">Google Scholar</a>
       
</div>
</li>

              
<li> 
  <p>World Health Organization. <i>Vaccination in Acute Humanitarian Emergencies: A Framework for Decision Making</i>. <a href="https://apps.who.int/iris/bitstream/handle/10665/255575/WHO-IVB-17.03-eng.pdf?sequence=1" target="_blank">https://apps.who.int/iris/bitstream/handle/10665/255575/WHO-IVB-17.03-eng.pdf?sequence=1</a>. Published May 2017. Accessed November 11, 2019.</p>

</li>

              
<li> 
  <p>Dhama K, Karthik K, Khandia R, et al. Advances in designing and developing vaccines, drugs, and therapies to counter Ebola virus. <i>Front Immunol</i>. 2018;9:1803.</p>

<div class="joe__references__item-links">
	
         <a href="https://doi.org/10.3389/fimmu.2018.01803">View Article</a>
       <a href="https://www.ncbi.nlm.nih.gov/pubmed?term=2018%5Bpdat%5D%20AND%20Advances%20in%20designing%20and%20developing%20vaccines%2C%20drugs%2C%20and%20therapies%20to%20counter%20Ebola%20virus&amp;TransSchema=title&amp;cmd=detailssearch">PubMed</a>
       <a href="https://scholar.google.com/scholar_lookup?title=Advances%20in%20designing%20and%20developing%20vaccines%2C%20drugs%2C%20and%20therapies%20to%20counter%20Ebola%20virus&amp;author=Dhama%20K%2C%20Karthik%20K%2C%20Khandia%20R%2C%20et%20al.&amp;publication_year=2018">Google Scholar</a>
       
</div>
</li>

              
<li> 
  <p>Krubiner CB, Faden RR, Karron RA, et al. Pregnant women and vaccines against emerging epidemic threats: ethics guidance for preparedness, research, and response [published online ahead of print May 3, 2019]. <i>Vaccine</i>.</p>

<div class="joe__references__item-links">
	
         <a href="https://doi.org/10.1016/j.vaccine.2019.01.011">View Article</a>
       <a href="https://www.ncbi.nlm.nih.gov/pubmed?term=Pregnant%20women%20and%20vaccines%20against%20emerging%20epidemic%20threats%3A%20ethics%20guidance%20for%20preparedness%2C%20research%2C%20and%20response&amp;TransSchema=title&amp;cmd=detailssearch">PubMed</a>
       <a href="https://scholar.google.com/scholar_lookup?title=Pregnant%20women%20and%20vaccines%20against%20emerging%20epidemic%20threats%3A%20ethics%20guidance%20for%20preparedness%2C%20research%2C%20and%20response%20%5Bpublished%20online%20ahead%20of%20print%20May%203%2C%202019%5D&amp;author=Krubiner%20CB%2C%20Faden%20RR%2C%20Karron%20RA%2C%20et%20al.&amp;publication_year=2019">Google Scholar</a>
       
</div>
</li>

              
<li>
         Jacobsen KH,       Aguirre AA,       Bailey CL,       et al.       
               <span>Lessons from the Ebola outbreak: action items for emerging infectious disease preparedness and response.</span>
       
               <span><i>Ecohealth</i>.</span>
        
 2016;13(1):200-212. 
<div class="joe__references__item-links">
	
         <a href="https://doi.org/10.1007/s10393-016-1100-5">View Article</a>
       <a href="https://www.ncbi.nlm.nih.gov/pubmed?term=13%5Bvolume%5D%20AND%201%5Bissue%5D%20AND%20200%5Bpage%5D%20AND%202016%5Bpdat%5D%20AND%20Lessons%20from%20the%20Ebola%20outbreak%3A%20action%20items%20for%20emerging%20infectious%20disease%20preparedness%20and%20response&amp;TransSchema=title&amp;cmd=detailssearch">PubMed</a>
       <a href="https://scholar.google.com/scholar_lookup?title=Lessons%20from%20the%20Ebola%20outbreak%3A%20action%20items%20for%20emerging%20infectious%20disease%20preparedness%20and%20response&amp;author=Jacobsen%20KH%2C%20Aguirre%20AA%2C%20Bailey%20CL%2C%20et%20al.&amp;publication_year=2016">Google Scholar</a>
       
</div>
</li>

              
<li> 
  <p>World Health Organization. Prioritizing diseases for research and development in emergency contexts. <a href="https://www.who.int/blueprint/priority-diseases/en/" target="_blank">https://www.who.int/blueprint/priority-diseases/en/</a>. Updated February 6, 2018. Accessed July 18, 2019.</p>

</li>

              
<li> 
  <p>Keusch G, McAdam KPWJ, Cuff PA, Mancher M, Busta ER, eds; National Academies of Sciences, Engineering, and Medicine. <i>Integrating Clinical Research into Epidemic Response: The Ebola Experience.</i> Wasington, DC: National Academies Press; 2017.</p>

<div class="joe__references__item-links">
	
         <a href="https://scholar.google.com/scholar_lookup?title=Integrating%20Clinical%20Research%20into%20Epidemic%20Response%3A%20The%20Ebola%20Experience&amp;author=Keusch%20G%2C%20McAdam%20KPWJ%2C%20Cuff%20PA%2C%20Mancher%20M%2C%20Busta%20ER%2C%20eds%3B%20National%20Academies%20of%20Sciences%2C%20Engineering%2C%20and%20Medicine.&amp;publication_year=2017">Google Scholar</a>
       
</div>
</li>

              
<li>
         Moodley K,       Hardie K,       Selgelid MJ,       et al.       
               <span>Ethical considerations for vaccination programmes in acute humanitarian emergencies.</span>
       
               <span><i>Bull World Health Organ</i>.</span>
        
 2013;91(4):290-297. 
<div class="joe__references__item-links">
	
         <a href="https://doi.org/10.2471/BLT.12.113480">View Article</a>
       <a href="https://www.ncbi.nlm.nih.gov/pubmed?term=Ethical%20considerations%20for%20vaccination%20programmes%20in%20acute%20humanitarian%20emergencies&amp;TransSchema=title&amp;cmd=detailssearch">PubMed</a>
       <a href="https://scholar.google.com/scholar_lookup?title=Ethical%20considerations%20for%20vaccination%20programmes%20in%20acute%20humanitarian%20emergencies&amp;author=Moodley%20K%2C%20Hardie%20K%2C%20Selgelid%20MJ%2C%20et%20al.&amp;publication_year=2013">Google Scholar</a>
       
</div>
</li>

              
<li> 
  <p>Tengbeh AF, Enria L, Smout E, et al. “We are the heroes because we are ready to die for this country”: participants’ decision-making and grounded ethics in an Ebola vaccine clinical trial. <i>Soc Sci Med</i>. 2018;203:35-42.</p>

<div class="joe__references__item-links">
	
         <a href="https://doi.org/10.1016/j.socscimed.2018.03.008">View Article</a>
       <a href="https://www.ncbi.nlm.nih.gov/pubmed?term=We%20are%20the%20heroes%20because%20we%20are%20ready%20to%20die%20for%20this%20country%E2%80%9D%3A%20participants%27%20decision-making%20and%20grounded%20ethics%20in%20an%20Ebola%20vaccine%20clinical%20trial&amp;TransSchema=title&amp;cmd=detailssearch">PubMed</a>
       <a href="https://scholar.google.com/scholar_lookup?title=%E2%80%9CWe%20are%20the%20heroes%20because%20we%20are%20ready%20to%20die%20for%20this%20country%E2%80%9D%3A%20participants%92%20decision-making%20and%20grounded%20ethics%20in%20an%20Ebola%20vaccine%20clinical%20trial&amp;author=Tengbeh%20AF%2C%20Enria%20L%2C%20Smout%20E%2C%20et%20al.&amp;publication_year=2018">Google Scholar</a>
       
</div>
</li>

              
<li> 
  <p>Kummervold PE, Schulz WS, Smout E, Fernandez-Luque L, Larson HJ. Controversial Ebola vaccine trials in Ghana: a thematic analysis of critiques and rebuttals in digital news. <i>BMC Public Health</i>. 2017;17(1):642.</p>

<div class="joe__references__item-links">
	
         <a href="https://doi.org/10.1186/s12889-017-4618-8">View Article</a>
       <a href="https://www.ncbi.nlm.nih.gov/pubmed?term=17%5Bvolume%5D%20AND%201%5Bissue%5D%20AND%20642%5Bpage%5D%20AND%202017%5Bpdat%5D%20AND%20Controversial%20Ebola%20vaccine%20trials%20in%20Ghana%3A%20a%20thematic%20analysis%20of%20critiques%20and%20rebuttals%20in%20digital%20news&amp;TransSchema=title&amp;cmd=detailssearch">PubMed</a>
       <a href="https://scholar.google.com/scholar_lookup?title=Controversial%20Ebola%20vaccine%20trials%20in%20Ghana%3A%20a%20thematic%20analysis%20of%20critiques%20and%20rebuttals%20in%20digital%20news&amp;author=Kummervold%20PE%2C%20Schulz%20WS%2C%20Smout%20E%2C%20Fernandez-Luque%20L%2C%20Larson%20HJ.&amp;publication_year=2017">Google Scholar</a>
       
</div>
</li>

        
            </ol>
          </div>
                <footer class="joe__article-footer">

          
          <h3 class="joe__title-label">Citation</h3>
          <div>
            <em>AMA J Ethics.</em> 2020;22(1):E43-49.
          </div>
          <h3 class="joe__title-label">DOI</h3>
          
            10.1001/amajethics.2020.43.
      
                                <h3 class="joe__title-label">Conflict of Interest Disclosure</h3>
            
            <p>Dr Asundi is an investigator for studies sponsored by Merck and Gilead Sciences. Dr Bhadelia had no conflicts of interest to disclose.</p>

      
                                <small>
            <p>The viewpoints expressed in this article are those of the author(s) and do not necessarily reflect the views and policies of the AMA.</p>

      </small>
                  </footer>
                  <aside class="joe__author-information">
            <h3 class="joe__title-label">Author Information</h3>
            <ul class="joe__author-information__list">
                              <li>  <div class="paragraph paragraph--type--author paragraph--view-mode--article-biography">
          <p><strong>Archana  Asundi, MD</strong> is a postdoctoral research fellow in the Section of Infectious Diseases at Boston University School of Medicine in Massachusetts, where she coordinates and oversees the conduct of studies concerning HIV translational research at the Center for Infectious Diseases at Boston Medical Center.</p>

      </div>
</li>
                              <li>  <div class="paragraph paragraph--type--author paragraph--view-mode--article-biography">
          <p><strong>Nahid  Bhadelia, MD</strong> is an assistant professor in the Section of Infectious Diseases at Boston University School of Medicine in Massachusetts, where she is also the medical director of the Special Pathogens Unit. She oversees the medical response program for Boston University’s maximum containment biosafety level 4 program at the National Emerging Infectious Diseases Laboratories and previously served as a clinician in several Ebola treatment units during the West African epidemic.</p>

      </div>
</li>
                          </ul>
          </aside>
              </div>
    </div>

          <aside id="sidebar" class="joe__sidebar joe__sidebar--top" role="complementary">
                  
                
  
<aside class="joe__rail-cta ">
<h3 class="joe__rail-cta__title"><span>Call for Papers</span>
</h3>
	<div class="joe__rail-cta__text">
		<p>
            <p>We invite submission of manuscripts for peer review on upcoming theme issues.</p>

      </p>
	</div>
		<a href="https://joe-prod.ama-assn.org/call-papers-0" class="joe__button joe__button--small" title="alt">Upcoming Themes
	</a>
	</aside>

              
  
<aside class="joe__rail-cta joe__rail-cta--secondary">
<h3 class="joe__rail-cta__title"><span>Stay Up-to-Date</span>
</h3>
	<div class="joe__rail-cta__text">
		<p>
            <p>Get monthly alerts when a new issue is published.</p>

      </p>
	</div>
		<a href="https://joe-prod.ama-assn.org/email-signup" class="joe__button joe__button--small" title="alt">Sign up
	</a>
	</aside>

        
                        <aside class="joe__related-articles">
          <h3 class="joe__rail-title">You may also be interested in</h3>
                                          
<article class="joe__article-teaser">
  <div class="joe__article-teaser__block">
    <div class="joe__flag joe__flag--green">
      <div class="joe__flag__type">
      
      </div>
              <time datetime="2015-12-01T12:00:00Z">Dec 2015</time>

  
    </div>
    <h2 class="joe__article-teaser__title"><a href="/article/expanded-access-investigational-drugs-what-physicians-and-public-need-know-about-fda-and-corporate/2015-12" class="joe__article-teaser__title"><span property="schema:name">Expanded Access to Investigational Drugs: What Physicians and the Public Need to Know about FDA and Corporate Processes</span>
</a></h2>
    <span class="joe__article-teaser__meta">
    

 Paige E. Finkelstein    </span>
  </div>
</article>

                              
<article class="joe__article-teaser">
  <div class="joe__article-teaser__block">
    <div class="joe__flag joe__flag--orange">
      <div class="joe__flag__type">
      
      </div>
              <time datetime="2006-08-01T12:00:00Z">Aug 2006</time>

  
    </div>
    <h2 class="joe__article-teaser__title"><a href="/article/lessons-dermatology-research-protecting-vulnerable-research-participants/2006-08" class="joe__article-teaser__title"><span property="schema:name">Lessons in Dermatology Research: Protecting Vulnerable Research Participants</span>
</a></h2>
    <span class="joe__article-teaser__meta">
    

 T. Howard Stone, JD, LLM    </span>
  </div>
</article>

                              
<article class="joe__article-teaser">
  <div class="joe__article-teaser__block">
    <div class="joe__flag joe__flag--blue">
      <div class="joe__flag__type">
      
      </div>
              <time datetime="2008-08-01T12:00:00Z">Aug 2008</time>

  
    </div>
    <h2 class="joe__article-teaser__title"><a href="/article/role-independent-advocates-research-subjects-who-are-child-wards-state/2008-08" class="joe__article-teaser__title"><span property="schema:name">Role of Independent Advocates for Research Subjects Who Are Child Wards of the State</span>
</a></h2>
    <span class="joe__article-teaser__meta">
    

 Hafzah Mueenuddin, JD and  Eric D. Kodish, MD    </span>
  </div>
</article>

                              
<article class="joe__article-teaser">
  <div class="joe__article-teaser__block">
    <div class="joe__flag joe__flag--green">
      <div class="joe__flag__type">
      
      </div>
              <time datetime="2011-07-01T12:00:00Z">Jul 2011</time>

  
    </div>
    <h2 class="joe__article-teaser__title"><a href="/article/vulnerable-populations-medicine-race-and-presumptions-identity/2011-07" class="joe__article-teaser__title"><span property="schema:name">“Vulnerable” Populations: Medicine, Race, and Presumptions of Identity</span>
</a></h2>
    <span class="joe__article-teaser__meta">
    

 Karla F.C. Holloway, PhD, MLS    </span>
  </div>
</article>

                              
<article class="joe__article-teaser">
  <div class="joe__article-teaser__block">
    <div class="joe__flag joe__flag--blue">
      <div class="joe__flag__type">
      
      </div>
              <time datetime="2018-10-01T12:00:00Z">Oct 2018</time>

  
    </div>
    <h2 class="joe__article-teaser__title"><a href="/article/why-marginalization-not-vulnerability-can-best-identify-people-need-special-medical-and-nutrition/2018-10" class="joe__article-teaser__title"><span property="schema:name">Why Marginalization, Not Vulnerability, Can Best Identify People in Need of Special Medical and Nutrition Care</span>
</a></h2>
    <span class="joe__article-teaser__meta">
    

 Alexis K. Walker, PhD and  Elizabeth L. Fox, PhD    </span>
  </div>
</article>

                                                    
<div class="views-element-container">
		 

	
	 
</div>

                    </aside>
              </aside>
    </article>

  
  
        </div>
  </main> 
       
    
       <section class="joe__article-issue-footer">
        <div class="container">
      <h3 class="joe__title-label">Also in this Issue</h3>
      <h4 class="joe__title-label">Jan 2020</h4>
      <div class="joe__layout--two-column joe__article-issue-footer__block">
        <div class="joe__col-one--med">
                      
<article class="joe__article-teaser joe__article-teaser--reverse">
  <a href="/article/burnout/2020-01" class="joe__article-teaser__image">
        <img alt="" src="/sites/journalofethics.ama-assn.org/files/styles/teaser_image_style_450x225_/public/2019-11/artm1-2001.jpg?itok=lCu7eJhe">
  </a>
  
  <div class="joe__article-teaser__block">
          <div class="joe__flag joe__flag--blue">
          <div class="joe__flag__type">
            
            Art of Medicine
      
          </div>
      </div>
        <h2 class="joe__article-teaser__title"><a href="/article/burnout/2020-01" class="joe__article-teaser__title"><span property="schema:name">Burnout</span>
</a></h2>
    <span class="joe__article-teaser__meta">
      

 Matt Heenan    </span>
  </div>
</article>

                      
<article class="joe__article-teaser joe__article-teaser--reverse">
  <a href="/article/how-should-clinicians-respond-international-public-health-emergencies/2020-01" class="joe__article-teaser__image">
        <img alt="" src="/sites/journalofethics.ama-assn.org/files/styles/teaser_image_style_450x225_/public/2019-11/cscm3-2001.jpg?itok=AlTvN6D4">
  </a>
  
  <div class="joe__article-teaser__block">
          <div class="joe__flag joe__flag--green">
          <div class="joe__flag__type">
            
            Case and Commentary
      
          </div>
      </div>
        <h2 class="joe__article-teaser__title"><a href="/article/how-should-clinicians-respond-international-public-health-emergencies/2020-01" class="joe__article-teaser__title"><span property="schema:name">How Should Clinicians Respond to International Public Health Emergencies?</span>
</a></h2>
    <span class="joe__article-teaser__meta">
      

 Abbey Lowe, MA, Angela Hewlett, MD, MS, and  Toby Schonfeld, PhD    </span>
  </div>
</article>

                  </div>
        <div class="joe__col-two--med">
                      
<article class="joe__article-teaser joe__article-teaser--reverse">
  <a href="/article/how-should-who-guide-access-and-benefit-sharing-during-infectious-disease-outbreaks/2020-01" class="joe__article-teaser__image">
        <img alt="" src="/sites/journalofethics.ama-assn.org/files/styles/teaser_image_style_450x225_/public/2019-11/nlit1-2001.jpg?itok=HbvYpOk2">
  </a>
  
  <div class="joe__article-teaser__block">
          <div class="joe__flag joe__flag--blue">
          <div class="joe__flag__type">
            
            In the Literature
      
          </div>
      </div>
        <h2 class="joe__article-teaser__title"><a href="/article/how-should-who-guide-access-and-benefit-sharing-during-infectious-disease-outbreaks/2020-01" class="joe__article-teaser__title"><span property="schema:name">How Should the WHO Guide Access and Benefit Sharing During Infectious Disease Outbreaks? </span>
</a></h2>
    <span class="joe__article-teaser__meta">
      

 Nicholas G. Evans, PhD, Kelly Hills, and  Adam C. Levine, MD    </span>
  </div>
</article>

                      
<article class="joe__article-teaser joe__article-teaser--reverse">
  <a href="/article/how-should-public-health-officials-respond-when-important-local-rituals-increase-risk-contagion/2020-01" class="joe__article-teaser__image">
        <img alt="" src="/sites/journalofethics.ama-assn.org/files/styles/teaser_image_style_450x225_/public/2019-11/cscm1-2001.jpg?itok=YPH3GxYA">
  </a>
  
  <div class="joe__article-teaser__block">
          <div class="joe__flag joe__flag--green">
          <div class="joe__flag__type">
            
            Case and Commentary
      
          </div>
      </div>
        <h2 class="joe__article-teaser__title"><a href="/article/how-should-public-health-officials-respond-when-important-local-rituals-increase-risk-contagion/2020-01" class="joe__article-teaser__title"><span property="schema:name">How Should Public Health Officials Respond When Important Local Rituals Increase Risk of Contagion?</span>
</a></h2>
    <span class="joe__article-teaser__meta">
      

 Esther Mokuwa, MSc and  Paul Richards,  PhD, MA    </span>
  </div>
</article>

                  </div>
      </div>
      <a href="/issue/culture-context-and-epidemic-containment" class="joe__link--reversed">View Full Issue</a>
    </div>
  </section>
 
  
             <footer class="joe__footer">
  <div class="container">
    <div class="joe__layout--66-33">
      <div class="joe__col-66">
        <div class="joe__wordmark">
          <a href="/">
            <h1 class="joe__wordmark__title">AMA Journal of Ethics<sup>®</sup></h1>
            <h2 class="joe__wordmark__subtitle">Illuminating the Art of Medicine</h2>
          </a>
        </div>
              <nav role="navigation" aria-labelledby="block-ama-joe-theme-footer-menu" id="block-ama-joe-theme-footer" class="joe__footer-nav">
            
  <h2 class="visually-hidden" id="block-ama-joe-theme-footer-menu">Footer menu</h2>
  

        
              <ul class="joe__footer-nav__list">
              <li class="joe__footer-nav__item">
        <a href="/about" data-drupal-link-system-path="node/16971">About</a>
              </li>
          <li class="joe__footer-nav__item">
        <a href="/conditions-use" data-drupal-link-system-path="node/16866">Conditions of Use</a>
              </li>
          <li class="joe__footer-nav__item">
        <a href="/privacy-policy" data-drupal-link-system-path="node/17456">Privacy Policy</a>
              </li>
          <li class="joe__footer-nav__item">
        <a href="/frequently-asked-questions" data-drupal-link-system-path="node/13781">FAQ</a>
              </li>
          <li class="joe__footer-nav__item">
        <a href="/contact-us" data-drupal-link-system-path="node/13786">Contact</a>
              </li>
        </ul>
  


  </nav>

   
      </div>
      <div class="joe__col-33">
        <a class="joe__footer-brand" href="https://www.ama-assn.org/">
        <img alt="American Medical Association" src="/themes/custom/ama_joe_theme/images/brand/logo.svg">
        </a>
      </div>
    </div>  
    <div class="joe__copyright joe__type--smaller">
      Copyright 2020 American Medical Association. All Rights Reserved. ISSN 2376-6980
    </div>
  </div>
</footer>
</div>
  </div>

    
    <script data-cfasync="false" src="/cdn-cgi/scripts/5c5dd728/cloudflare-static/email-decode.min.js"></script><script type="application/json" data-drupal-selector="drupal-settings-json">{"path":{"baseUrl":"\/","scriptPath":null,"pathPrefix":"","currentPath":"node\/19921","currentPathIsAdmin":false,"isFront":false,"currentLanguage":"en"},"pluralDelimiter":"\u0003","ajaxTrustedUrl":{"form_action_p_pvdeGsVG5zNF_XLGPTvYSKCf43t8qZYSwcfZl2uzM":true},"user":{"uid":0,"permissionsHash":"578807214e53851e1deff69e2c1877b74da07002551957e6252f9861db214380"}}</script>
<script src="/sites/journalofethics.ama-assn.org/files/js/js_dBV9AAuxl_7Q9NwGRIp_ok-y6LPtyck605oK06a1peY.js"></script>

  <script type="text/javascript">window.NREUM||(NREUM={});NREUM.info={"beacon":"bam.nr-data.net","licenseKey":"22656e4355","applicationID":"153878993","transactionName":"YFQDZhFVWUpRVUZYWlkeIFEXXVhXH0ZTVlBoUgBRC1E=","queueTime":0,"applicationTime":42,"atts":"TBMAEFlPSkQ=","errorBeacon":"bam.nr-data.net","agent":""}</script></body>
</html>
